Trial intelligence / Profile preview

Lonsurf in metastatic gastric cancer (TAGS)

NCT02500043Phase 3Completed

Sponsor
Taiho Oncology
Start
Feb 2016
Primary completion
Apr 2018
Modality
Small Molecules
Countries
18
01

Overview

A Phase 3 trial of trifluridine + tipiracil in gastric cancer (GC), gastroesophageal junction cancer, sponsored by Taiho Oncology. Started Feb 2016; status: completed.

02

Drugs

trifluridine + tipiracil
03

Conditions

gastric cancer (GC)gastroesophageal junction cancer

Beyond the preview

Go deeper on NCT02500043.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02500043.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call